# Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Randomized Against Valaciclovir - CYMEVALIII STEP1

> **NCT04732260** · NA · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 7 (actual)

## Conditions studied

- Pregnant Women Undergoing TOP
- TOP - Failed Attempted Termination of Pregnancy

## Interventions

- **DRUG:** Letermovir

## Key facts

- **NCT ID:** NCT04732260
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-11
- **Primary completion:** 2021-11-05
- **Final completion:** 2021-11-12
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2026-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04732260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04732260, "Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Randomized Against Valaciclovir - CYMEVALIII STEP1". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04732260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*